DANIEL P. GOLD PHD - 05 Jul 2022 Form 4 Insider Report for MEI Pharma, Inc. (MEIP)

Role
Chief Executive Officer, Director
Signature
/s/ Brian G. Drazba, as attorney in fact
Issuer symbol
MEIP
Transactions as of
05 Jul 2022
Net transactions value
$0
Form type
4
Filing time
07 Jul 2022, 16:25:40 UTC
Previous filing
06 Jul 2021
Next filing
12 Oct 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MEIP Stock Option (Right to Buy) Award $0 +1,496,000 $0.000000 1,496,000 05 Jul 2022 Common Stock 1,496,000 $0.5400 Direct F1
holding MEIP Stock Option (Right to Buy) 855,000 05 Jul 2022 Common Stock 855,000 $2.95 Direct F2
holding MEIP Stock Option (Right to Buy) 275,500 05 Jul 2022 Common Stock 275,500 $1.57 Direct F3
holding MEIP Stock Option (Right to Buy) 380,000 05 Jul 2022 Common Stock 380,000 $1.36 Direct F3
holding MEIP Stock Option (Right to Buy) 380,000 05 Jul 2022 Common Stock 380,000 $2.83 Direct F3
holding MEIP Stock Option (Right to Buy) 380,000 05 Jul 2022 Common Stock 380,000 $4.33 Direct F3
holding MEIP Stock Option (Right to Buy) 300,000 05 Jul 2022 Common Stock 300,000 $4.28 Direct F4
holding MEIP Stock Option (Right to Buy) 675,000 05 Jul 2022 Common Stock 675,000 $2.52 Direct F5
holding MEIP Stock Option (Right to Buy) 680,000 05 Jul 2022 Common Stock 680,000 $3.49 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 One-quarter of such options shall vest on July 5, 2023 and the remaining three-quarters of such options shall vest monthly over a three-year period beginning on July 5, 2023.
F2 One-quarter of such options vested on July 1, 2022 and the remaining three-quarters of such options shall vest monthly over a three-year period beginning on July 1, 2022.
F3 All of such options are presently exercisable.
F4 One-quarter of such options vested on July 12, 2019 and the remaining three-quarters of such options shall vest monthly over a three-year period beginning on July 12, 2019.
F5 One-quarter of such options vested on July 1, 2020 and the remaining three-quarters of such options shall vest monthly over a three-year period beginning on July 1, 2020.
F6 One-quarter of such options vested on July 2, 2021 and the remaining three-quarters of such options shall vest monthly over a three-year period beginning on July 2, 2021.